MXC
Mgc Pharmaceuticals
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 2 Apr 2024
- Reported shorts
- 218
- Shares on issue
- 43.852M
Mgc Pharmaceuticals (MXC) company profile
Profile, insiders and operations
Company
AI-generated research profile of Mgc Pharmaceuticals
biopharmaceuticals
cannabis
ASX
healthcare
innovation
MGC Pharmaceuticals is a biopharmaceutical company specializing in the production and development of phytocannabinoid-derived medicines. The company is positioned in the healthcare industry, focusing on innovative treatments for various medical conditions. MGC leverages its expertise in cannabis-based products to offer unique therapeutic solutions.
Director trades
No director trades found
MXC intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required